Kohlberg Kravis Roberts：LBO financing for PHC Holdings Corporation’s acquisition from Thermo Fisher Scientific Inc. of its anatomical pathology businesses
Leading Japanese law firm Nishimura & Asahi advised Kohlberg Kravis Roberts (“KKR”), a global investment firm, and PHC Holdings Corporation on the LBO financing for PHC Holdings’ acquisition of the anatomical pathology businesses of NYSE-listed Thermo Fisher Scientific Inc.
The Nishimura & Asahi team advising KKR and PHC Holdings was led by partner Hideo Horikoshi.
Hideo’s practice includes a broad mix of acquisition finance, project finance, cross-border syndicated lending, equity investment, and other innovative financing products. Hideo also has strong expertise in banking and frequently advises financial institutions, inter alia, on matters including debt restructuring and banking regulations. Leveraging his significant experience in investment-banking matters, he regularly advices financial institutions, major companies and governmental agencies on various corporate matters.